Literature DB >> 18245471

CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.

Viviana Vallacchi1, Maria Daniotti, Francesca Ratti, Delia Di Stasi, Paola Deho, Annamaria De Filippo, Gabrina Tragni, Andrea Balsari, Antonino Carbone, Licia Rivoltini, Giorgio Parmiani, Noureddine Lazar, Bernard Perbal, Monica Rodolfo.   

Abstract

CCN3/nephroblastoma overexpressed belongs to the CCN family of genes that encode secreted proteins associated with the extracellular matrix (ECM) and exert regulatory effects at the cellular level. Overexpression of CCN3 was shown in metastatic melanoma cells compared with cells of the primary tumor from the same patient. Analysis of short-term cultures from 50 primary and metastatic melanomas revealed a heterogeneous expression pattern of both the 46-kDa full-length cytoplasmic/secreted protein and the 32-kDa nuclear-truncated form. The different protein expression patterns were not associated with gene alterations or polymorphisms. Like the metastatic cells expressing high levels of the 46-kDa CCN3, cells transfected to overexpress CCN3 showed increased adhesion to ECM proteins, whereas inhibition of CCN3 expression by small interfering RNA decreased adhesion to laminin and vitronectin. CCN3 overexpression induced increased expression of laminin and vitronectin integrin receptors alpha 7 beta 1 and alpha v beta 5 by increasing their mRNA production. Moreover, CCN3 secreted by melanoma cells acted as an adhesion matrix protein for melanoma cells themselves. Analysis of CCN3 protein expression with respect to melanoma progression detected the protein in all visceral metastases tested and in most nodal metastases from relapsing patients but in only a few nodal metastases from nonrelapsing patients and cutaneous metastases. Consistently, xenotransplantation in immunodeficient mice showed a higher metastatic potential of melanoma cells overexpressing CCN3. Together, these data indicate a role for CCN3 in melanoma cell interaction with the ECM by regulating integrin expression, resulting in altered cell adhesion and leading melanoma progression to aggressive disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245471     DOI: 10.1158/0008-5472.CAN-07-2103

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.

Authors:  Véronique Ouellet; Kerstin Tiedemann; Anna Mourskaia; Jenna E Fong; Danh Tran-Thanh; Eitan Amir; Mark Clemons; Bernard Perbal; Svetlana V Komarova; Peter M Siegel
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

3.  CCN3: Doctor Jekyll and Mister Hyde.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2008-09-12       Impact factor: 5.782

4.  Spatial-temporal modulation of CCN proteins during wound healing in human skin in vivo.

Authors:  Laure Rittié; Bernard Perbal; John J Castellot; Jeffrey S Orringer; John J Voorhees; Gary J Fisher
Journal:  J Cell Commun Signal       Date:  2011-01-11       Impact factor: 5.782

5.  CCN proteins: A centralized communication network.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2013-02-19       Impact factor: 5.782

Review 6.  Conjunction junction, what's the function? CCN proteins as targets in fibrosis and cancers.

Authors:  Andrew Leask
Journal:  Am J Physiol Cell Physiol       Date:  2020-03-04       Impact factor: 4.249

7.  CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor.

Authors:  L Wu; C Runkle; H-J Jin; J Yu; J Li; X Yang; T Kuzel; C Lee; J Yu
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

8.  Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization.

Authors:  Wun-Chey Sin; Mimi Tse; Nathalie Planque; Bernard Perbal; Paul D Lampe; Christian C Naus
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

9.  Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.

Authors:  Chantragan Srisomsap; Phannee Sawangareetrakul; Pantipa Subhasitanont; Daranee Chokchaichamnankit; Khajeelak Chiablaem; Vaharabhongsa Bhudhisawasdi; Sopit Wongkham; Jisnuson Svasti
Journal:  J Biomed Biotechnol       Date:  2009-12-27

10.  Alternative splicing of CCN mRNAs .... it has been upon us.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2009-04-28       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.